SFB 914 Trafficking of Immune Cells in Inflammation, Development and Disease
print

Links and Functions

Breadcrumb Navigation


Content

Cathepsin G may provide novel strategy for treatment of arterial inflammation

Collaborative paper published in Circulation

29.09.2016

The article “Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment” led by Almudena Ortega-Gomez and senior author Oliver Söhnlein describes a novel mechanism, by which Cathepsin G (CatG) plays a central role for the adhesion of leukocytes in arterial vessels. This newly identified mechanism is only active in arteries, but not in venular vessels.

CatG is immobilized specifically on arterial endothelium and causes leukocytes to activate and initiate firm adherence through the help of subsequent integrin clustering. Neutralizing antibodies against CatG can specifically block this activation step, while leaving myeloid cell adhesion in the microcirculation unaffected.

news_soehnlein_circulation2016CCL5 and Cathepsin G accumulate at the lumen of carotid arteries; displayed is a part of a carotid artery after the mouse has received a high fat diet for four weeks; CCL5 in green, Cathepsin G in red, endothelial CD31 in blue.

Clinical implications

The recruitment of leukocytes in arterial vessels is a main contributor to the development of atherosclerosis. Yet, this process could so far not be inhibited by therapeutic means. The newly identified central role of Cathepsin G and the potential to block it, however, opens an approach to therapeutically inhibit this process specifically in arterial vessels and reduce arterial inflammation.

Collaborative effort amongst SFB groups

This publication has been a collaborative effort between three projects of SFB 914, namely project B08 (Oliver Söhnlein/Christian Weber), project A02 (Barbara Walzog), and project Z03 (Christoph Scheiermann).

The paper also marks the first publication with a contribution by SFB 914’s central service platform Z03 Spinning-disk confocal microscopy (SDCM). The SDCM platform was established at the beginning of the second funding period in 2015 and provides high-definition as well as ultra-fast 4D imaging of leukocyte trafficking and localization in time and space.

F1000 Prime recommendation

The article was featured in the F1000 Prime Article Recommendation section:
http://f1000.com/prime/726766757

Publication:

Ortega Gomez A, Salvermoser M, Rossaint J, Pick R, Brauner J, Lemnitzer P, Tilgner J, de Jong R, Megens RT, Jamasbi J, Döring Y, Pham CT, Scheiermann C, Siess W, Drechsler M, Weber C, Grommes J, Zarbock A, Walzog B, Soehnlein O. (2016)
Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.
Circulation 134(16):1176-1188

Contact:

Prof. Dr. Dr. med. Oliver Söhnlein
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten (IPEK)
Klinikum der Universität München
Pettenkoferstr. 8
80336 München

Tel.: +49 (0)89-4400-54677
Oliver.Soehnlein@med.uni-muenchen.de


Service